Cargando…

Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling

The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Kaifeng, Lu, Junxi, Huang, Yan, Wu, Mian, Zhang, Lei, Yu, Haoyong, Zhang, Mingliang, Bao, Yuqian, He, John Cijiang, Chen, Haibing, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390193/
https://www.ncbi.nlm.nih.gov/pubmed/25853493
http://dx.doi.org/10.1371/journal.pone.0125176
_version_ 1782365653625208832
author Guo, Kaifeng
Lu, Junxi
Huang, Yan
Wu, Mian
Zhang, Lei
Yu, Haoyong
Zhang, Mingliang
Bao, Yuqian
He, John Cijiang
Chen, Haibing
Jia, Weiping
author_facet Guo, Kaifeng
Lu, Junxi
Huang, Yan
Wu, Mian
Zhang, Lei
Yu, Haoyong
Zhang, Mingliang
Bao, Yuqian
He, John Cijiang
Chen, Haibing
Jia, Weiping
author_sort Guo, Kaifeng
collection PubMed
description The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1α-overexpressing plasmid (pcDNA3-PGC-1α) for 48 h. In the diabetic rats, decreased PGC-1α expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1α, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1α. These data suggest that PGC-1α may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN.
format Online
Article
Text
id pubmed-4390193
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43901932015-04-21 Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling Guo, Kaifeng Lu, Junxi Huang, Yan Wu, Mian Zhang, Lei Yu, Haoyong Zhang, Mingliang Bao, Yuqian He, John Cijiang Chen, Haibing Jia, Weiping PLoS One Research Article The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1α-overexpressing plasmid (pcDNA3-PGC-1α) for 48 h. In the diabetic rats, decreased PGC-1α expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1α, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1α. These data suggest that PGC-1α may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN. Public Library of Science 2015-04-08 /pmc/articles/PMC4390193/ /pubmed/25853493 http://dx.doi.org/10.1371/journal.pone.0125176 Text en © 2015 Guo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Guo, Kaifeng
Lu, Junxi
Huang, Yan
Wu, Mian
Zhang, Lei
Yu, Haoyong
Zhang, Mingliang
Bao, Yuqian
He, John Cijiang
Chen, Haibing
Jia, Weiping
Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title_full Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title_fullStr Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title_full_unstemmed Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title_short Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
title_sort protective role of pgc-1α in diabetic nephropathy is associated with the inhibition of ros through mitochondrial dynamic remodeling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390193/
https://www.ncbi.nlm.nih.gov/pubmed/25853493
http://dx.doi.org/10.1371/journal.pone.0125176
work_keys_str_mv AT guokaifeng protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT lujunxi protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT huangyan protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT wumian protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT zhanglei protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT yuhaoyong protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT zhangmingliang protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT baoyuqian protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT hejohncijiang protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT chenhaibing protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling
AT jiaweiping protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling